Search Results - Jorge Gomez‐Galeno
- Showing 1 - 3 results of 3
-
1
Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ by Cecilia Hurtado, A. G. Safarova, Michael P. Smith, Raeeun Chung, Arne A.N. Bruyneel, Jorge Gomez‐Galeno, Franz Oswald, Christopher J. Larson, John R. Cashman, Pilar Ruiz‐Lozano, Philip Janiak, Teri Suzuki, Mark Mercola
Published 2019Artigo -
2
Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity by Wesley L. McKeithan, Dries Feyen, Arne A.N. Bruyneel, Karl J. Okolotowicz, Daniel A. J. Ryan, Kevin J. Sampson, F Potet, A. K. Savchenko, Jorge Gomez‐Galeno, Michelle M. Vu, Ricardo Serrano, Alfred L. George, Robert S. Kass, John R. Cashman, Mark Mercola
Published 2020Artigo -
3
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis by Jorge Gomez‐Galeno, Qun Dang, Thanh H. Nguyen, Serge H. Boyer, Matthew P. Grote, Zhili Sun, Mingwei Chen, William A. Craigo, Paul D. van Poelje, Deidre A. MacKenna, Edward E. Cable, Paul Rolzin, Patricia D. Finn, Bert Chi, David L. Linemeyer, Scott J. Hecker, Mark D. Erion
Published 2010Artigo
Search Tools:
Related Subjects
Chemistry
Gene
Biology
Genetics
Signal transduction
AMP-activated protein kinase
AMPK
Activator (genetics)
Biochemistry
Bioinformatics
C2C12
Cancer research
Cell biology
Computational biology
Cyclin-dependent kinase 8
Drug
Drug discovery
Effector
Embryonic stem cell
Gene silencing
HEK 293 cells
Induced pluripotent stem cell
Internal medicine
Kinase
Lipid metabolism
Lipogenesis
Long QT syndrome
Medicine
Mexiletine
Myocyte